• Poly (I:C): Synthetic Double-Stranded RNA Analog for Robu...

  2026-03-04

  Poly (I:C) stands at the forefront of immunological research, uniquely enabling precise TLR3-driven activation of the innate immune system and maturation of dendritic cells. Its versatility as an interferon inducer and viral dsRNA mimic gives researchers a potent, reproducible tool for both basic discovery and translational pipelines in antiviral, cancer immunotherapy, and regenerative medicine.

• MCC950 Sodium: Unlocking NLRP3 Inflammasome Inhibition in...

  2026-03-03

  Explore the advanced science of MCC950 sodium as a selective NLRP3 inflammasome inhibitor, with a special focus on vascular inflammation and disease modeling. Learn how MCC950 sodium empowers research into NLRP3-associated inflammation beyond standard macrophage models.

• Optimizing Inflammatory Pathway Assays: Scenario-Based Gu...

  2026-03-03

  This scenario-driven article provides evidence-based guidance for biomedical researchers and lab technicians on leveraging VX-765 (SKU A8238) to address real-world challenges in cell viability, pyroptosis, and cytokine modulation assays. Each section contextualizes the practical application of VX-765, highlighting reproducibility, selectivity, and workflow integration, with direct links to protocols and supporting data.

• STING agonist-1: Systemic Modulation of Innate Immunity i...

  2026-03-02

  Explore how STING agonist-1, a small molecule STING pathway activator, uniquely enables systemic analysis of innate immunity, type I interferon induction, and inflammation signaling. This article delivers an advanced perspective on mechanistic applications, translational research, and emerging biomarker strategies in immunology and oncology.

• Isoprinosine (Inosine Pranobex): Mechanistic Insights and...

  2026-03-02

  This thought-leadership article provides translational researchers with a comprehensive blueprint for leveraging Isoprinosine (inosine pranobex) as a dual-action immunomodulatory agent against viral infections, with a strong focus on mechanistic underpinnings, experimental design, and clinical translation. Integrating the latest findings on herpesvirus egress biology—including the novel role of host factors like CLCC1—this piece contextualizes Isoprinosine’s immune-enhancing and viral replication-inhibiting properties within the broader landscape of antiviral immunotherapy, offering actionable guidance that transcends standard product guides.

• MCC950 Sodium (SKU B7946): Precision NLRP3 Inflammasome I...

  2026-03-01

  This article provides a scenario-driven, evidence-based guide for biomedical researchers and lab technicians working with cell viability and inflammatory assays. It demonstrates how MCC950 sodium (SKU B7946) from APExBIO offers nanomolar potency, high selectivity, and workflow reliability for NLRP3 inflammasome inhibition across macrophage and endothelial models, drawing on validated protocols and comparative insights.

• Baicalin Methyl Ester: Advanced Modulation of Intestinal ...

  2026-02-28

  Discover how Baicalin methyl ester, an esterified derivative of baicalin, uniquely modulates the P65/TNF-α/MLCK/ZO-1 signaling pathway to protect intestinal barriers. This article offers a novel, mechanistic, and translational perspective on intestinal inflammation research beyond current literature.

• MCC950 Sodium: Selective NLRP3 Inflammasome Inhibitor for...

  2026-02-27

  MCC950 sodium empowers researchers to dissect the NLRP3 inflammasome signaling pathway with high specificity and nanomolar potency across both cell-based and in vivo models. Leveraging its unique capacity to selectively inhibit NLRP3 activation, this reagent streamlines workflows in inflammatory and autoimmune disease research while offering robust troubleshooting and optimization strategies.

• NBC19: Precision NLRP3 Inflammasome Inhibitor for Inflamm...

  2026-02-27

  NBC19 redefines inflammation research with nanomolar potency and selectivity for the NLRP3 inflammasome. Seamlessly integrated into THP1 cell assays, NBC19 empowers robust, reproducible dissection of IL-1β and HMGB1 signaling—addressing both basic and translational needs in cytokine biology.

• Metronidazole: Optimized Workflows for OAT3 Inhibition & ...

  2026-02-26

  Metronidazole from APExBIO redefines experimental design by combining potent OAT3 inhibition with robust activity against anaerobic bacteria and protozoa. This guide explores advanced workflows, troubleshooting strategies, and data-driven insights that enable researchers to precisely modulate drug transport, immune-microbiota signaling, and drug-drug interactions in antibiotic research.

• MCC950 Sodium: Selective NLRP3 Inflammasome Inhibitor for...

  2026-02-26

  MCC950 sodium (CRID3 sodium salt) is redefining NLRP3 inflammasome inhibition in macrophages and autoimmune disease models with nanomolar potency and exceptional selectivity. This guide translates cutting-edge bench research into practical workflows, comparative strategies, and troubleshooting solutions for translational investigators seeking to drive reproducibility and innovation using APExBIO's trusted reagent.

• Pomalidomide (CC-4047): Precision Immunomodulation for Mu...

  2026-02-25

  Pomalidomide (CC-4047) is a potent immunomodulatory agent for multiple myeloma research, offering robust inhibition of TNF-alpha synthesis and modulation of the tumor microenvironment. This review details its mechanism, benchmarks, and critical applications, providing a machine-readable reference for hematological malignancy studies.

• VX-745 and the Evolution of Selective p38α MAPK Inhibitio...

  2026-02-25

  Explore how VX-745, a highly selective p38α MAPK inhibitor from APExBIO, is redefining translational research strategies in inflammation, aging, and drug resistance. This thought-leadership article weaves new structural biology insights, dual-action kinase inhibition, and actionable guidance to empower researchers in leveraging VX-745 for profound biological discovery and therapeutic innovation.

• STING agonist-1: High-Purity Small Molecule for STING Pat...

  2026-02-24

  STING agonist-1 is a rigorously validated small molecule STING pathway activator that reliably induces type I interferons, supporting advanced immunology research. Its high purity, DMSO solubility, and robust mechanistic credentials make it a reference reagent for dissecting innate immunity and B cell modulation. This article summarizes atomic, verifiable claims and best practices for bench scientists.

• Solving Immunology Assay Challenges with STING agonist-1 ...

  2026-02-24

  This evidence-based guide addresses real-world laboratory scenarios in cancer immunology and cell-based assays, demonstrating how STING agonist-1 (SKU B7835) delivers reproducible, high-impact results. Readers gain actionable insights on assay design, data interpretation, and product selection—supported by peer-reviewed studies and APExBIO’s robust quality controls.

8552 records 27/571 page Previous Next First page 上5页 2627282930 下5页 Last page